Prospective, Longitudinal, Multi-Center, Descriptive Registry of Patients Receiving Therapy Other Than Surgical Resection Alone for Newly Diagnosed Head and Neck Cancer

Inclusion Criteria:

- Pathologically (histologically or cytologically) confirmed new diagnosis of carcinoma
involving the oral cavity, oropharynx, nasopharynx, hypopharynx, larynx, or neck node
metastasis from unknown origin

- Scheduled to receive radiotherapy and/or drug therapy including chemotherapy,
biologic therapy and targeted therapy

- Written informed consent

Exclusion Criteria:

- Registry participation does not exclude participation in clinical trials.

- Patients scheduled to receive or who have received surgery are eligible for Registry
participation as long as they are also scheduled to receive medical therapy.